Back





       OzStar Therapeutics


            OzStar Therapeutics Pty Ltd © 2016                                                   Privacy Policy                                                        info@ozstartherapeutics.com


Health Centre Point is seeking patient with the following criteria to participate in a clinical trial. Please read the information below to find out if you are
eligible to participate in this clinical trial.

Trial registration number:     ACTRN12614000836639
Registry name:                     ANZCTR   
Universal Trial Number:        U1111-1158-9653
HREC Approval Number:      2014-10-542
Protocol:                               OZ-14-101
Protocol Version:                  01_V06 FINAL


In Search of Type 2 Diabetes Mellitus Patients

Have you been diagnosed with Type 2 Diabetes Mellitus within the past 1 to 10 years?

For the past 6 months, have you been taking sulphonylurea-only medication to treat your diabetes such as:

1)        Glibenclamide, also known as
                         Daonil
                         Glimel

2)        Gliclazide, also known as
                         Apotek-Gliclazide
                         Chemmart-Gliclazide
                         Diamicron
                         GenRx-Gliclazide
                         Melihexal
                         Nidem
                         Oziclide MR

3)        Glipizide, also known
                         Glucotrol
                         Minidiab

4)        Glimepiride, also known as
                         Amaryl
                         Apo-Glimepiride
                         Aylide
                         Diapride
                         Dimirel
                         Glimepiride Sandoz

The Health Centre Point is seeking volunteer Type 2 diabetes patients to participate in a clinical study, that will investigate if an investigational drug
(OZ101), taken in combination with your sulphonylurea-only medication, results in better control of blood glucose and improves the treatment of type 2
diabetes.

If you are between 25 to 65 years of age and your condition has been stable for the past 3 months then you may be eligible to participate in this study.

For more information please contact (02) 8883 0800
OR (02) 8883 0811 OR healthcentrepoint@gmail.com OR info@ozstartherapeutics.com.

For further information please also visit http://healthcentrepoint.com.au/.         



OZ-14-101 Trial Advertisement (Version 3)                                                                   29 October 2015
Patient Information